These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 2957465

  • 1. Comparison of the effects of dopamine D1 and D2 receptor antagonists on rat striatal, limbic and nigral dopamine synthesis and utilisation.
    Magnusson O, Mohringe B, Fowler CJ.
    J Neural Transm; 1987; 69(3-4):163-77. PubMed ID: 2957465
    [Abstract] [Full Text] [Related]

  • 2. Effects of d-amphetamine on dopaminergic neurotransmission; a comparison between the substantia nigra and the striatum.
    Elverfors A, Nissbrandt H.
    Neuropharmacology; 1992 Jul; 31(7):661-70. PubMed ID: 1328918
    [Abstract] [Full Text] [Related]

  • 3. The regulation of dopamine release from nigrostriatal neurons in conscious rats: the role of somatodendritic autoreceptors.
    Santiago M, Westerink BH.
    Eur J Pharmacol; 1991 Oct 29; 204(1):79-85. PubMed ID: 1687125
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum.
    Nissbrandt H, Sundström E, Jonsson G, Hjorth S, Carlsson A.
    J Neurochem; 1989 Apr 29; 52(4):1170-82. PubMed ID: 2564423
    [Abstract] [Full Text] [Related]

  • 5. Selective antagonists of dopamine receptor subtypes differentially affect substance P levels in the striatum and substantia nigra.
    Oblin A, Zivkovic B, Bartholini G.
    Brain Res; 1987 Sep 22; 421(1-2):387-90. PubMed ID: 2446703
    [Abstract] [Full Text] [Related]

  • 6. Characterization of dopaminergic influence on striatal-nigral neurotensin systems.
    Letter AA, Matsuda LA, Merchant KM, Gibb JW, Hanson GR.
    Brain Res; 1987 Sep 29; 422(1):200-3. PubMed ID: 3119151
    [Abstract] [Full Text] [Related]

  • 7. Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo.
    Zetterström T, Sharp T, Ungerstedt U.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct 29; 334(2):117-24. PubMed ID: 2946964
    [Abstract] [Full Text] [Related]

  • 8. Effects of the dopamine D2 selective receptor antagonist remoxipride on dopamine turnover in the rat brain after acute and repeated administration.
    Magnusson O, Mohringe B, Thorell G, Lake-Bakaar DM.
    Pharmacol Toxicol; 1987 May 29; 60(5):368-73. PubMed ID: 2886989
    [Abstract] [Full Text] [Related]

  • 9. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.
    Nissbrandt H, Engberg G, Pileblad E.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul 29; 344(1):16-28. PubMed ID: 1663587
    [Abstract] [Full Text] [Related]

  • 10. The D1 agonist SKF 38393 increases dopamine release in the developing rat striatum.
    Walters DE, Howard SG.
    Eur J Pharmacol; 1990 Aug 10; 184(2-3):257-64. PubMed ID: 2150376
    [Abstract] [Full Text] [Related]

  • 11. Characterization and pharmacological responsiveness of dopamine release recorded by microdialysis in the substantia nigra of conscious rats.
    Santiago M, Westerink BH.
    J Neurochem; 1991 Sep 10; 57(3):738-47. PubMed ID: 1677674
    [Abstract] [Full Text] [Related]

  • 12. [The effects of dopamine D-1 and D-2 receptor antagonists on 3,4-dihydroxyphenylacetic acid (DOPAC) in rat striatum with differential normal pulse voltammetry].
    Wang X, Niu X.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1992 Aug 10; 14(4):257-62. PubMed ID: 1473213
    [Abstract] [Full Text] [Related]

  • 13. Early increase in dopamine release in the ipsilateral striatum after unilateral intranigral administration of lactacystin produces spontaneous contralateral rotations in rats.
    Konieczny J, Lenda T, Czarnecka A.
    Neuroscience; 2016 Jun 02; 324():92-106. PubMed ID: 26964686
    [Abstract] [Full Text] [Related]

  • 14. Modulation of acetylcholine release by D1, D2 dopamine receptors in rat striatum under freely moving conditions.
    Ajima A, Yamaguchi T, Kato T.
    Brain Res; 1990 Jun 04; 518(1-2):193-8. PubMed ID: 1975213
    [Abstract] [Full Text] [Related]

  • 15. Dopamine D2 receptors and dopamine metabolism. Relationship between biochemical and behavioural effects of substituted benzamide drugs.
    Magnusson O, Fowler CJ, Köhler C, Ogren SO.
    Neuropharmacology; 1986 Feb 04; 25(2):187-97. PubMed ID: 2939362
    [Abstract] [Full Text] [Related]

  • 16. Apomorphine-haloperidol interactions: different types of antagonism in cortical and subcortical brain regions.
    Bacopoulos NG, Roth RH.
    Brain Res; 1981 Feb 02; 205(2):313-9. PubMed ID: 7470869
    [Abstract] [Full Text] [Related]

  • 17. Turnover of dopamine and dopamine metabolites in rat brain: comparison between striatum and substantia nigra.
    Nissbrandt H, Carlsson A.
    J Neurochem; 1987 Sep 02; 49(3):959-67. PubMed ID: 3612134
    [Abstract] [Full Text] [Related]

  • 18. In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists.
    See RE, Sorg BA, Chapman MA, Kalivas PW.
    Neuropharmacology; 1991 Dec 02; 30(12A):1269-74. PubMed ID: 1686300
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. YM-09151-2 but not l-sulpiride induces transient dopamine release in rat striatum via a tetrodotoxin-insensitive mechanism.
    Tomiyama K, Noguchi M, Koshikawa N, Kobayashi M.
    J Neurochem; 1993 May 02; 60(5):1690-5. PubMed ID: 8473891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.